Status:
COMPLETED
Radiofrequency Intervention in Neurological Pathologies Post COVID-19
Lead Sponsor:
Clinica Gema Leon
Conditions:
Covid19
Neurological Injury
Eligibility:
All Genders
Phase:
NA
Brief Summary
The sequelae that occur in post-COVID-19 patients are multiple and, at a therapeutic level, these represent a new challenge within the general context of the pandemic that the world is suffering. The...
Detailed Description
The new post-pandemic era has left sequelae in patients who presented the signs and symptoms of SARS-CoV-2 and subsequently faced a positive for COVID-19. Such sequelae will be evident at various syst...
Eligibility Criteria
Inclusion
- Have passed the covid-19 disease without any previos pathology.
- Have olfactory and gustatory disorders one month later of COVID-19
Exclusion
- Have passed the covid-19 disease with previous pathology, or not having passed the covid-19 disease.
- Have contraindications for the application of Indiba, such as pregnancy, pacemaker or thrombophlebitis
Key Trial Info
Start Date :
June 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04920890
Start Date
June 16 2021
End Date
July 20 2022
Last Update
June 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gema León Physiotherapy and Rehabilitation Clinic
Córdoba, Andalusia, Spain, 14011